4.3 Article

The Procurement of Cells for the Derivation of Human Embryonic Stem Cell Lines for Therapeutic Use: Recommendations for Good Practice

Journal

STEM CELL REVIEWS AND REPORTS
Volume 8, Issue 1, Pages 91-99

Publisher

SPRINGER
DOI: 10.1007/s12015-011-9288-9

Keywords

Human embryonic stem cells; Embryo research; Embryo donation; Regulation; Stem cell banks; Cell therapy; Stem cell therapy; Donor screening; Donor testing

Funding

  1. Medical Research Council
  2. BBSRC [BB/J021636/1] Funding Source: UKRI
  3. MRC [G0801057, G0801061, G1001045, G0700092, G0300484] Funding Source: UKRI
  4. Biotechnology and Biological Sciences Research Council [BB/J021636/1] Funding Source: researchfish
  5. Medical Research Council [G0700092, G1001045, G0801061, G0801057, G0300484, G0400232] Funding Source: researchfish

Ask authors/readers for more resources

The donation of human embryos for the derivation of embryonic stem cell lines that may be used in the development of therapeutic products raises more complex ethical, practical and regulatory problems than the donation of embryos for non-clinical research. This review considers these issues and offers recommendations for good practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available